These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25745341)

  • 1. Significant Association between Serum Levels of Von Willebrand Factor (vWF) Antigen with Stages of Cirrhosis.
    Yilmaz VT; Dincer D; Avci AB; Cetinkaya R
    Eurasian J Med; 2015 Feb; 47(1):21-5. PubMed ID: 25745341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. von Willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia.
    Kalambokis GN; Oikonomou A; Christou L; Kolaitis NI; Tsianos EV; Christodoulou D; Baltayiannis G
    J Hepatol; 2016 Nov; 65(5):921-928. PubMed ID: 27297911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The clinical value of von Willebrand factor and VITRO score in evaluating disease progression in patients with HBV infection].
    Guan YL; Zhang DZ; Yang YX; Wan RJ; Tang LQ; Zeng WQ; Kang J
    Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):309-315. PubMed ID: 35462488
    [No Abstract]   [Full Text] [Related]  

  • 4. Ratio of von Willebrand factor antigen to ADAMTS13 activity is a useful biomarker for acute-on-chronic liver failure development and prognosis in patients with liver cirrhosis.
    Enomoto M; Takaya H; Namisaki T; Fujinaga Y; Nishimura N; Sawada Y; Kaji K; Kawaratani H; Moriya K; Akahane T; Inoue T; Matsumoto M; Yoshiji H
    Hepatol Res; 2022 Apr; 52(4):390-400. PubMed ID: 34964539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
    Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A
    Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Von Willebrand factor could be an index of endothelial dysfunction in patients with cirrhosis: relationship to degree of liver failure and nitric oxide levels.
    Albornoz L; Alvarez D; Otaso JC; Gadano A; Salviú J; Gerona S; Sorroche P; Villamil A; Mastai R
    J Hepatol; 1999 Mar; 30(3):451-5. PubMed ID: 10190728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C.
    Maieron A; Salzl P; Peck-Radosavljevic M; Trauner M; Hametner S; Schöfl R; Ferenci P; Ferlitsch M
    Aliment Pharmacol Ther; 2014 Feb; 39(3):331-8. PubMed ID: 24308724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen.
    Stufano F; Lawrie AS; La Marca S; Berbenni C; Baronciani L; Peyvandi F
    Haemophilia; 2014 Jan; 20(1):147-53. PubMed ID: 24028703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Von-Willebrand factor as a predictor of three-month mortality in patients with liver cirrhosis compared to MELD score.
    Curakova Ristovska E; Genadieva-Dimitrova M; Caloska-Ivanova V; Misevski J
    Acta Gastroenterol Belg; 2019; 82(4):487-493. PubMed ID: 31950803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.
    Takaya H; Namisaki T; Kitade M; Kaji K; Nakanishi K; Tsuji Y; Shimozato N; Moriya K; Seki K; Sawada Y; Saikawa S; Sato S; Kawaratani H; Akahane T; Noguchi R; Matsumoto M; Yoshiji H
    BMC Gastroenterol; 2019 Oct; 19(1):167. PubMed ID: 31638892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo.
    Geisen U; Zieger B; Nakamura L; Weis A; Heinz J; Michiels JJ; Heilmann C
    Thromb Res; 2014 Aug; 134(2):246-50. PubMed ID: 24891215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes.
    Tobin WO; Kinsella JA; Kavanagh GF; O'Donnell JS; McGrath RT; Tierney S; Egan B; Feeley TM; Coughlan T; Collins DR; O'Neill D; Murphy S; Lim SJ; Murphy RP; McCabe D
    J Neurol Sci; 2017 Apr; 375():404-410. PubMed ID: 28320178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of Von Willebrand factor antigen plasma levels in children with acute lung injury.
    El Basset Abo El Ezz AA; Abd El Hafez MA; El Amrousy DM; El Momen Suliman GA
    Pediatr Pulmonol; 2017 Jan; 52(1):91-97. PubMed ID: 27362747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Von Willebrand factor antigen for detection of hepatopulmonary syndrome in patients with cirrhosis.
    Horvatits T; Drolz A; Roedl K; Herkner H; Ferlitsch A; Perkmann T; Müller C; Trauner M; Schenk P; Fuhrmann V
    J Hepatol; 2014 Sep; 61(3):544-9. PubMed ID: 24798623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory diagnostic approach of the parents-children relationship in differentiating low-level von Willebrand factor from mild type 1 von Willebrand disease.
    Akin M
    Blood Coagul Fibrinolysis; 2012 Jun; 23(4):351-3. PubMed ID: 22450546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
    Lippi G; Franchini M; Salvagno GL; Montagnana M; Poli G; Guidi GC
    J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of von-Willebrand factor in patients with liver cirrhosis and its relation to other prognostic indicators.
    Curakova Ristovska E; Genadieva-Dimitrova M
    World J Hepatol; 2022 Apr; 14(4):812-826. PubMed ID: 35646274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?
    Favaloro EJ; Thom J; Patterson D; Just S; Dixon T; Koutts J; Baccala M; Rowell J; Baker R
    Thromb Res; 2009 Apr; 123(6):862-8. PubMed ID: 19064279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.